Contact
Please use this form to send email to PR contact of this press release:
Allakos Announces Phase 1 Trial Results of Subcutaneous AK006 in Healthy Volunteers
TO:
Please use this form to send email to PR contact of this press release:
Allakos Announces Phase 1 Trial Results of Subcutaneous AK006 in Healthy Volunteers
TO: